Background The low and highly variable oral bioavailability of the immunosuppressant
sirolimus is thought to result partly from genetic polymorphism of the CYP3A5 gene. Methods …

There are no studies which have compared the risk of severe COVID‐19 and related mortality
between transplant recipients and nontransplant patients. We enrolled two groups of …

Autosomal dominant polycystic kidney disease ( ADPKD ), the most common inherited kidney
disorder, is characterized by the progressive development and expansion of bilateral fluid‐…

First-line therapy of minimal change nephrotic syndrome (MCNS) in adults is extrapolated
largely from pediatric studies and consists of high-dose oral corticosteroids. We assessed …

In 2007, a consortium of European experts on tacrolimus (TAC) met to discuss the most
recent advances in the drug/dose optimization of TAC taking into account specific clinical …

Introduction and Aims: Autosomal dominant polycystic kidney disease (ADPKD) is one of the
most common genetic disorders, affecting 1 in 1000 people. Polycystins 1 and 2 account for …

With the increasing use of mycophenolic acid (MPA) in solid organ transplantation, the need
for more accurate drug dosing has become evident. Personalized immunosuppressive …

Background. Cytomegalovirus (CMV) infection is a major complication after renal transplantation
and is involved in graft rejection. The anti-interleukin-2-receptor antibody daclizumab …

Background The immunosuppressive drug cyclosporine (INN, ciclosporin), whose pharmacokinetic
characteristics vary greatly among individuals, is a substrate for cytochrome P450 (…

2 Objectifs L’objectif principal de cette étude est d’avoir une photographie des pratiques d’utilisation
des ASE pour les patients en prédialyse, en France, suivis par des néphrologues, et …